131 related articles for article (PubMed ID: 2474417)
1. Ciliated ovarian adenocarcinoma cells in ascitic fluid cytology: report of a case with immunocytochemical features.
Kobayashi TK; Teraoka S; Tsujioka T; Yoshida Y
Diagn Cytopathol; 1988; 4(3):234-8. PubMed ID: 2474417
[TBL] [Abstract][Full Text] [Related]
2. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
[TBL] [Abstract][Full Text] [Related]
3. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms.
Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J
Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907
[TBL] [Abstract][Full Text] [Related]
4. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
[TBL] [Abstract][Full Text] [Related]
5. Application of immunocytochemistry to the cytologic study of peritoneal fluids in patients with ovarian cancer.
Shinozuka T; Ebisawa K; Miyamoto T; Murakami M; Fujii A; Osamura Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1355-62. PubMed ID: 1955789
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of cilia in exfoliated ovarian adenocarcinoma cells.
Gupta PK; Albritton N; Erozan YS; Frost JK
Diagn Cytopathol; 1985; 1(3):228-31. PubMed ID: 3836089
[TBL] [Abstract][Full Text] [Related]
7. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
Macdonald F; Bird R; Stokes H; Russell B; Crocker J
J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
[TBL] [Abstract][Full Text] [Related]
8. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
[TBL] [Abstract][Full Text] [Related]
9. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
10. The expression of CEA, CA 19-9 and HMFG antigens in ovarian clear-cell and endometrioid carcinomas.
Helle M; Helin H; Ashorn P; Putkinen EL; Krohn K; Wahlström T
Pathol Res Pract; 1992 Feb; 188(1-2):74-7. PubMed ID: 1594502
[TBL] [Abstract][Full Text] [Related]
11. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
[TBL] [Abstract][Full Text] [Related]
13. Cytological Findings of Ascitic Fluid with a Malignant Ovarian Steroid Cell Tumor: A Case Report and Literature Review.
Kosaka N; Hasegawa K; Kiuchi K; Ochiai S; Nagai T; Machida H; Imai Y; Fukasawa I
Acta Cytol; 2017; 61(2):165-171. PubMed ID: 28343229
[TBL] [Abstract][Full Text] [Related]
14. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
Qian HN; Feng J; Fu TY
Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
[TBL] [Abstract][Full Text] [Related]
15. Ascitic fluid cytology of yolk sac tumor of the ovary: a case report.
Petrakakou E; Grapsa D; Stergiou ME; Mikou P; Tsarpalis D; Polyzos A; Giahnaki A; Ioakim-Liossi A
Acta Cytol; 2009; 53(6):701-3. PubMed ID: 20014563
[TBL] [Abstract][Full Text] [Related]
16. Tumour associated antigens in diagnosis of serous effusions.
Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
[TBL] [Abstract][Full Text] [Related]
17. Cytologic findings in peritoneal fluids from patients with ovarian serous adenocarcinoma.
Kashimura M; Matsukuma K; Kamura T; Matsuyama T; Tsukamoto N
Diagn Cytopathol; 1986; 2(1):13-6. PubMed ID: 3720477
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
19. CA125 in peritoneal fluid of ovarian cancer patients.
Vergote IB; Onsrud M; Børmer OP; Sert BM; Moen M
Gynecol Oncol; 1992 Feb; 44(2):161-5. PubMed ID: 1544593
[TBL] [Abstract][Full Text] [Related]
20. Cytology of ascitic fluid in a patient with metastasizing malignant Brenner tumor of the ovary. A case report.
Ahr A; Arnold G; Göhring UJ; Costa S; Scharl A; Gauwerky JF
Acta Cytol; 1997; 41(4 Suppl):1299-304. PubMed ID: 9990262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]